Necrotizing external otitis on a Crohn's disease patient treated with infliximab.
Gabriela
G
Duque
Francisco
F
Portela
Maria Carmo
MC
Migueis
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D004424:Ear Canal / Q000473:pathology*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D000069285:Infliximab; D009336:Necrosis; D009894:Opportunistic Infections / Q000150:complications*; D010032:Otitis Externa / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab